QP-Prostate® CAD vs ProstatID

Direct competitors — feature-level head-to-head below. Comparability 92/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

QP-Prostate® CAD

by Quibim S.L.

ProstatID

by ScanMed

AI Verdict

Both QP-Prostate® CAD and ProstatID are FDA-cleared, cloud-based AI solutions for prostate cancer detection and diagnosis using MRI, positioning them as direct competitors. QP-Prostate® CAD offers detailed quantitative metrics, PI-RADS structured reporting, and AI-powered image quality assessment. ProstatID highlights its role in reducing false positives and aiding treatment planning through AI-powered image interpretation and 3D modeling.

Choose QP-Prostate® CAD if…

Choose QP-Prostate® CAD if your workflow demands comprehensive quantitative analysis, including detailed perfusion metrics and prostate segmentation, alongside automated MRI image quality assessment. This tool is ideal for radiologists seeking a PI-RADS 2.1 structured report template and seamless integration with fusion biopsy systems for precise pre-biopsy planning and post-biopsy correlation.

View QP-Prostate® CAD →

Choose ProstatID if…

Choose ProstatID if your primary focus includes prostate cancer screening in addition to detection and diagnosis, aiming to significantly reduce false positives. This solution is particularly well-suited for practices looking for an FDA-cleared AI tool that aids in treatment planning through advanced AI-powered image interpretation and 3D modeling capabilities.

View ProstatID →

When considering AI tools for prostate MRI interpretation, QP-Prostate® CAD and ProstatID both offer FDA-cleared solutions to enhance diagnostic accuracy. QP-Prostate® CAD, developed by Quibim S.L., excels in providing comprehensive quantitative data, including prostate volume, ADC maps, and perfusion metrics. It also features a PI-RADS 2.1 structured report template and AI-QUAL™ for automated image quality assessment. This makes it particularly well-suited for radiologists who prioritize detailed quantitative analysis and standardized reporting in their workflow.

ProstatID, from ScanMed, distinguishes itself as an AI software for prostate cancer screening, detection, and diagnosis with a focus on reducing false positives and aiding in treatment planning through AI-powered image interpretation and 3D modeling. While both tools integrate into existing radiology workflows, a key practical difference lies in QP-Prostate® CAD’s extensive quantitative feature set and image quality assessment capabilities. Physicians seeking a tool that offers in-depth quantitative metrics and automated quality control for prostate MRI should lean towards QP-Prostate® CAD. Conversely, those primarily focused on optimizing screening and detection with an emphasis on reducing false positives and leveraging 3D modeling for treatment planning might find ProstatID to be a more direct fit for their needs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	QP-Prostate® CAD	ProstatID
Pricing	Contact for pricing	Not publicly available
Deployment	Cloud-based, with integration into standard reading environments (PACS) and AI marketplaces.	SaaS (Software as a Service), cloud-based, secure VPN connection, PACS to PACS integration.
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

QP-Prostate® CAD

QP-Prostateu00ae CAD offers a PI-RADS 2.1 structured report template and seamless integration into PACS and fusion biopsy systems, which directly streamlines radiologists' workflows and reporting. Its integration into AI marketplaces also suggests broader accessibility. While ProstatID offers PACS integration and 3D modeling, QP-Prostate's explicit mention of a structured report template provides a clearer advantage in daily usability for radiologists.

Clinical Value

QP-Prostate® CAD

QP-Prostateu00ae CAD provides a more comprehensive suite of clinical features, including automatic lesion detection with risk scoring, quantitative information such as ADC maps and perfusion metrics, prostate segmentation, and AI-QUALu2122 for automated image quality assessment based on PI-QUAL v2 guidelines. These detailed features offer richer diagnostic insights and support for clinical decision-making. ProstatID also enhances diagnostic accuracy and aids in treatment planning, but its described features are less specific.

Pricing & Value

ProstatID

ProstatID offers a slight edge in pricing transparency by indicating a 'Per-click cost; percentage of sales' model, even though specific figures are not public. In contrast, QP-Prostateu00ae CAD only states 'Contact for pricing.' This minimal insight into the pricing structure provides a clearer understanding of potential cost implications for Tool B.

Enterprise Readiness

QP-Prostate® CAD

Both tools are FDA-cleared, HIPAA compliant, cloud-based, and integrate with PACS, demonstrating strong enterprise readiness. However, QP-Prostateu00ae CAD's explicit mention of integration into 'AI marketplaces' suggests potentially broader and more flexible deployment options within diverse enterprise IT ecosystems.

Innovation

QP-Prostate® CAD

QP-Prostateu00ae CAD showcases more specific innovative features, such as AI-QUALu2122 for automated prostate MRI image quality assessment based on PI-QUAL v2 guidelines and detailed quantitative perfusion metrics (K trans, K ep, V e). These capabilities go beyond basic detection to offer advanced analytical and quality control functionalities. While ProstatID highlights its 3D modeling and claim of being 'North America's first and only' FDA-cleared software for screening, detection, and diagnosis, QP-Prostate's feature set appears more technologically advanced in its AI-driven analyses.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details regarding dedicated support channels, service level agreements (SLAs), or comprehensive user documentation for either QP-Prostateu00ae CAD or ProstatID. Therefore, it is not possible to distinguish between the two tools in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	QP-Prostate® CAD	ProstatID
Name	QP-Prostateu00ae CAD	ProstatID
Company	Quibim S.L.	ScanMed
Tagline	Your AI solution for advanced prostate cancer detection.	North America's first and only FDA-Cleared AI software for the Screening, Detection and Diagnosis of Prostate Cancer.
Categories	Oncology AI	Oncology AI
Specialties	Oncology, Radiology, Urology	Oncology, Radiology, Urology

Videos

Demos, reviews, and walkthroughs featuring QP-Prostate® CAD and ProstatID.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific diagnostic and reporting features differentiate QP-Prostateu00ae CAD and ProstatID?

QP-Prostateu00ae CAD offers automatic lesion detection with high and moderate risk scoring, quantitative metrics for prostate volume, ADC maps, and perfusion, along with a PI-RADS 2.1 structured report template and prostate segmentation. ProstatID focuses on enhancing diagnostic accuracy, reducing false positives, and aiding in treatment planning through AI-powered image interpretation and 3D modeling, also providing a suggested PI-RADS exam score.

How do the integration capabilities of QP-Prostateu00ae CAD and ProstatID compare within a radiology practice?

QP-Prostateu00ae CAD is cloud-based and integrates into standard reading environments (PACS) and AI marketplaces, with seamless integration into fusion biopsy systems. ProstatID is a cloud-based SaaS solution that offers secure VPN connection and PACS to PACS integration, designed for a zero-click workflow.

Do both tools offer advanced visualization or quantitative analysis beyond basic lesion detection?

QP-Prostateu00ae CAD provides advanced viewing with 3D visualization and offers extensive quantitative information including prostate volume, ADC maps, and perfusion metrics. ProstatID also aids in treatment planning through AI-powered image interpretation and 3D modeling, presenting high-risk lesions in two powerful 3D views.

Does either tool provide features for assessing the quality of prostate MRI images?

Yes, QP-Prostateu00ae CAD includes AI-QUALu2122 for automated prostate MRI image quality assessment based on PI-QUAL v2 guidelines, which helps streamline workflows and supports diagnostic confidence. ProstatID's description does not explicitly mention an image quality assessment feature.

What is the basis for the AI algorithms used in each tool?

QP-Prostateu00ae CAD's AI algorithms are trained on actual pathology/biopsy data, with the training dataset including cases from multiple centers, magnetic fields, and vendors. ProstatID's AI was trained by analyzing thousands of MRI scans, radiological interpretations, biopsies, and pathology lab results.